What is the recommended treatment for rectal Chlamydia trachomatis and Neisseria gonorrhoeae infection in a male who has sex with men?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Rectal Chlamydia and Gonorrhea in MSM

For rectal chlamydia and gonorrhea in men who have sex with men, treat with ceftriaxone 500 mg IM once PLUS doxycycline 100 mg orally twice daily for 7 days.

Recommended Treatment Regimen

The most current CDC guidance 1 from 2020 updated the gonorrhea treatment to ceftriaxone 500 mg IM as a single dose (increased from the previous 250 mg dose). For concurrent chlamydia coverage when infection has not been excluded, doxycycline 100 mg orally twice daily for 7 days is recommended 1.

Why This Specific Regimen?

For Gonorrhea:

  • Ceftriaxone remains the only reliably effective first-line treatment as quinolone resistance is now widespread, particularly among MSM 2
  • The 500 mg dose provides adequate tissue penetration for rectal infections 1
  • Single IM injection ensures treatment completion and directly observed therapy

For Chlamydia:

  • Doxycycline is definitively superior to azithromycin for rectal chlamydia 3, 4, 5
  • Multiple studies show azithromycin efficacy for rectal chlamydia is only 79-94% compared to near 100% for doxycycline 3
  • The 7-day doxycycline course is critical—do not substitute single-dose azithromycin for rectal infections 4, 5

Critical Pitfalls to Avoid

Do NOT Use Azithromycin Monotherapy for Rectal Chlamydia

While older guidelines 6, 7, 8 listed azithromycin 1 g as equivalent to doxycycline, recent evidence conclusively demonstrates azithromycin is significantly less effective for rectal chlamydia infections 4, 5. This is particularly important in MSM populations where rectal infections predominate.

Do NOT Use Quinolones in MSM

Quinolone resistance in gonorrhea is extremely high among MSM (23.9% in surveillance data) 2. Fluoroquinolones should never be used for gonorrhea treatment in this population 2, 1.

Do NOT Use Cefixime as First-Line

While cefixime 400 mg orally appears in older guidelines 9, 2, 8, it provides lower and less sustained bactericidal levels than ceftriaxone and is reserved only as an alternative when IM ceftriaxone cannot be given 9.

Anatomic Site Considerations

Rectal infections require the same treatment as urogenital infections with the critical exception that doxycycline (not azithromycin) must be used for chlamydia 3, 1. The rectal site does not require dose adjustment for gonorrhea, but the chlamydia treatment choice is absolutely critical.

Treatment Completion and Follow-Up

  • Instruct patients to abstain from sexual activity for 7 days after completing the full doxycycline course 7
  • Test-of-cure is not routinely needed for uncomplicated infections treated with recommended regimens 6, 8
  • However, if symptoms persist or treatment failure is suspected, perform culture with antimicrobial susceptibility testing 9, 1
  • Retest in 3 months due to high reinfection rates in MSM populations 10

Partner Management

All sexual partners within the preceding 60 days must be evaluated and treated for both gonorrhea and chlamydia, regardless of symptoms 6, 8. Patients should avoid sexual contact until both they and their partners complete treatment 6.

Alternative Regimens (Only if Ceftriaxone Unavailable or Severe Allergy)

If ceftriaxone cannot be administered:

  • Cefixime 400 mg orally once PLUS doxycycline 100 mg orally twice daily for 7 days 9
  • Requires test-of-cure at 1 week 9
  • Consult infectious disease specialist for cephalosporin allergy 9

Never substitute azithromycin for doxycycline in rectal infections, even in alternative regimens.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.